Neisseria meningitidis with decreased susceptibility to penicillin in Saskatchewan, Canada. 1995

J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
Department of Clinical Microbiology, St. Paul's Hospital, Saskatoon, Ottawa, Canada.

Moderately penicillin-resistant Neisseria meningitidis is rare in North America. We report an outbreak of meningococcal disease in Saskatoon, Saskatchewan, Canada, with serogroup C N. meningitidis. The MICs of penicillin ranged from 0.12 to 0.25 micrograms/ml, and all isolates showing decreased susceptibility had identical genomic fingerprints when they were compared by pulsed-field gel electrophoresis. Our data indicate that N. meningitidis that is moderately resistant to penicillin is prevalent in Saskatchewan, Canada.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008585 Meningitis, Meningococcal A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D005260 Female Females

Related Publications

J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
May 2001, Canada communicable disease report = Releve des maladies transmissibles au Canada,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
May 1987, The Pediatric infectious disease journal,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
January 2002, Scandinavian journal of infectious diseases,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
April 1997, Anales espanoles de pediatria,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
August 2004, Antimicrobial agents and chemotherapy,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
October 2004, The Medical journal of Malaysia,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
September 1988, Medicina clinica,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
September 1988, Medicina clinica,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
December 1993, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J M Blondeau, and F E Ashton, and M Isaacson, and Y Yaschuck, and C Anderson, and G Ducasse
December 2001, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!